CQP · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $10.76B | $8.70B | $9.66B | $17.20B | $9.44B | $6.17B | $6.84B | $6.43B |
| Cost of Revenue | — | — | — | — | — | — | — | $3.40B |
| Research & Development | — | — | — | — | $1.00M | $0.00 | $0.00 | $2.00M |
| Selling, General & Administrative | $105.00M | $100.00M | $99.00M | $97.00M | $94.00M | $14.00M | $11.00M | $11.00M |
| Operating Expenses | $7.05B | $5.42B | $4.63B | $13.83B | $6.88B | $4.04B | $4.80B | $4.45B |
| Operating Income | $3.71B | $3.28B | $5.04B | $3.38B | $2.56B | $2.13B | $2.04B | $1.98B |
| Interest Expense | — | — | $823.00M | $870.00M | $831.00M | $909.00M | $885.00M | $733.00M |
| Other Income / (Expense) | -$719.00M | -$770.00M | -$782.00M | -$882.00M | -$927.00M | -$942.00M | -$865.00M | -$705.00M |
| Provision for Income Taxes | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| Net Income | $2.99B | $2.51B | $4.25B | $2.50B | $1.63B | $1.18B | $1.18B | $1.27B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $4.26 | $4.25 | $4.26 | 2 | ↑2 ↓0 |
| Dec 2027 | $4.05 | $3.56 | $4.71 | 6 | ↑2 ↓2 |
| Dec 2028 | $4.07 | $3.20 | $4.84 | 5 | ↑3 ↓0 |
| Dec 2029 | $4.04 | $4.04 | $4.04 | 1 | ↑0 ↓0 |